Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens (SIMPLIFI)
Evaluation of a Single Use Point of Care Device for the Diagnosis of Influenza and Other Respiratory Pathogens in Clinical Upper Airway Samples Using Isothermal Amplification - a Feasibility Study
Sponsor: Imperial College London
Terminated
Terminated due to covid-19- not reinstated due to low flu admissions
Listed as NCT04431050, this observational or N/A phase trial focuses on Enterovirus Infections and Human Influenza and remains terminated or withdrawn. Sponsored by Imperial College London, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Mar 2025 — Present [monthly]
Terminated
Status: Unknown → Terminated
-
Sep 2024 — Mar 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Jul 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Imperial College London
- Sense Biodetection Limited
For direct contact, visit the study record on ClinicalTrials.gov .